Showing posts with label Carestream Health. Show all posts
Showing posts with label Carestream Health. Show all posts

Monday 3 December 2018

Veterinary Imaging Market Expected To Trigger A Revenue Increase To USD 3.27 Billion By 2025:Key Participant Carestream Health, and FUJIFILM Holdings America Corporation


San Francisco, 03 December 2018,  The global veterinary Imaging Market is expected to reach USD 3.27 billion by 2025, according to a new report by Grand View Research, Inc. The veterinary medicine field experienced immense technological developments in the last 20 years. Various technologies of human medical practice are being adopted for diagnosis and treatment of animals. Advancements in technologies are expected to fuel growth. For instance, launch of portable imaging equipment with battery charge is propelling the adoption of these systems in the following years.
Magnetic Resonance Imaging (MRI) and ultrasound analysis are some of the advanced technologies. MRIs are effective in the prognosis of human neurological disorders. These days, veterinarians are using MRIs for the examination of animal brains. This technology also helps in diagnosing soft tissues and orthopedic structure of an animal’s body. MRI has applications in cardiology for studying heart diseases.
Imaging devices help veterinarians and technicians in the diagnosis and management of zoonotic diseases. These instruments also assist in the diagnosis of injuries. Increasing adoption of advanced technologies coupled with growing awareness about animal health are some of the factors expected to propel market growth in the coming years. For example, University of Pennsylvania’s School of Veterinary Medicine was the first to use EQUIMAGINE, a diagnostic tool for horses. This device has 2 imaging C-arms that help in scanning all body parts of a horse. It also captures 2D CT images. This system is also currently being used in the diagnosis of diseases that affect horses.
Access Full Research Report On Veterinary Imaging Market Analysis:
www.grandviewresearch.com/industry-analysis/veterinary-imaging-market

Further Key Findings From the Study Suggest: 
·         Increasing demand for minimally invasive diagnostic tools to reduce mortality and morbidity is anticipated to fuel the market growth.
·         Instruments held the dominant share owing to their increasing adoption in reference laboratories and other animal healthcare facilities
·         The MRI segment is expected to witness lucrative growth in the coming years owing to rising awareness about their benefits in animal disease diagnosis
·         Multi-slice CT scan systems are anticipated to gain popularity over the forecast period
·         Small companion animals held the dominant share as of 2016 owing to increasing adoption of pets and concern about their well-being
·         Veterinary hospitals accounted for the largest revenue share as of 2016 due to increase in adoption of imaging devices in animal health care facilities
·         The North America veterinary imaging market held the dominant share as of 2016 owing to increasing number of animal healthcare settings and awareness among pet owners in this region
·         Asia Pacific regional industry is expected to grow at a lucrative CAGR owing to increase in the number of veterinary care facilities and investments in animal healthcare
·         IDEXX Laboratories, Inc.; SOUND; GE Healthcare; and Toshiba Corporation held the dominant share of the market owing to their wide offerings of technologically advanced products and regional presence
·         Competitors are adopting strategies such as launch of new products, mergers & acquisitions, and regional expansion to gain competitive advantage
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented veterinary imaging market on the basis of the product, animal type, application, end use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Instrument
o    Radiography X-ray
o  Direct (Capture) Radiography
o  Computed Radiography
o  Film-based Radiography
o    Ultrasound Imaging
o  2D Ultrasound Imaging
o  3D/4D Ultrasound Imaging
o  Doppler Imaging
o    MRI
o    CT Imaging
o    Multi-slice CT
o    Single-slice CT
o    Video Endoscopy Imaging
o    Others
·         Reagent
o    Ultrasound Contrast Regents
o    MRI Contrast Regents
o    X-Ray/CT Contrast Reagents
o    Nuclear Imaging
·         Services
o    Interventional Radiology & Endoscopy
o    Teleradiology
o    Advanced Imaging Services
·         Veterinary PACS
o    RIS PACS
o    CVIS PACS
Animal Type Outlook (Revenue, USD Million, 2014 - 2025)
·         Small Companion Animals
·         Large Animals
·         Others
Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Orthopedics and Traumatology
·         Oncology
·         Cardiology
·         Neurology
·         Others
End-use Outlook (Revenue, USD Million, 2014 - 2025)
·         Hospitals/Clinics
·         Reference Laboratories
·         Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
o    France
o    Italy
o    Spain
·         Asia Pacific
o    Japan
o    China
o    India
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


Wednesday 14 November 2018

Cell Counting Market Expected To Trigger A Revenue Increase To 10,679.7 Million By 2025


San Francisco, 14 November 2018 ,  The global cell counting market is expected to reach USD 10,679.7 million by 2025, according to a new report by Grand View Research, Inc. Government initiatives working to promote development of cell therapeutics, wherein cell counting plays an imperative role, is expanding growth prospects for the market. As a result of extensive R&D activities, the number of diseases treated with the help of stem cells increased to 82 in 2016 from 27 in 2005. Also, California Institute for Regenerative Medicine’s funding of USD 271 million for stem cell therapy created 12 R&D facilities in California, and these facilities brought approximately USD 543 million funding. In addition, it is also funded by National Institutes of Health (NIH), which approximately invested USD 1,429 million in 2015.
Increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided significant boost to the market. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate generation of accurate results are likely to improve adoption of instruments over the coming years. For instance, in May 2016, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve quality of preclinical studies.
Full Research Report On Cell Counting Market Analysis:

Further Key Findings From the Report Suggest:
·         Spectrophotometers accounted forthe largest market share in 2016. This can be attributed to high penetration in various applications such as toxicology studies, bioprocessing, and others
·         Automated counters were anticipated to grow at an exponential rate during the forecast period. Benefits such as short testing time, reduced error occurrence, and interoperator variability are expected to further increase demand for automated counters
·         In the end-use segment, research and academic institutes accounted for the largest market share in 2016, owing to growing number of government initiatives focused toward promoting R&D in various toxicology studies
·         Research and academic institutes are also expected to witness exponential growth opportunities, owing to the growing adoption of instruments for optimum drug concentration in therapeutics
·         North America held the largest share of the market, owing to increase in number of supportive initiatives to fund R&D, which is anticipated to result in higher adoption of automated instruments
·         Asia Pacific is anticipated to grow with a lucrative CAGR during the forecast period. This lucrative growth rate is a consequence of improvements in testing facilities
·         Level of competition is high as key players are adopting strategies such as new product development and strategic collaborations & agreements to gain competitive advantage
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global cell counting market on the basis of product, end use, and region:
Cell Counting Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Instruments
o    Spectrophotometers
o    Flow Cytometers
o    Hematology Analyzers
o    Cell Counters
·         Consumables & Accessories
o    Reagents
o    Microplates
o    Others
Cell Counting End-use Outlook (Revenue, USD Million, 2014 - 2025)
·         Hospitals & Diagnostic Laboratories
·         Research & Academic Institutes
·         Pharmaceutical & Biotechnology Companies
·         Others
Cell Counting Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
o    France
o    Italy
o    Spain
·         Asia Pacific
o    Japan
o    China
o    India
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa
o    Saudi Arabia


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/